loadpatents
name:-0.03826904296875
name:-0.018916130065918
name:-0.014527082443237
Wong; Kwok-kin Patent Filings

Wong; Kwok-kin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wong; Kwok-kin.The latest application filed is for "combination therapy for treatment of lkb1 deficient cancers".

Company Profile
11.16.32
  • Wong; Kwok-kin - Arlington MA
  • Wong; Kwok-kin - Boston MA
  • Wong; Kwok-Kin - Chapel Hill NC
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors
Grant 11,446,309 - Bradner , et al. September 20, 2
2022-09-20
Methods of use and pharmaceutical combinations of HDAC inhibitors with BET inhibitors
Grant 11,298,354 - Wong , et al. April 12, 2
2022-04-12
Combination Therapy For Treatment Of Lkb1 Deficient Cancers
App 20220062260 - Peng; David ;   et al.
2022-03-03
EZH2 inhibitors and uses thereof
Grant 11,236,082 - Bradner , et al. February 1, 2
2022-02-01
Methods of diagnosing and prognosing lung cancer
Grant 11,009,508 - Wong , et al. May 18, 2
2021-05-18
Combination Therapy For Cancer Using Bromodomain And Extra-terminal (bet) Protein Inhibitors
App 20210100813 - Bradner; James E. ;   et al.
2021-04-08
Inhibitors Of Egfr And Methods Of Use Thereof
App 20210094913 - GRAY; Nathanael S. ;   et al.
2021-04-01
Compositions and methods for identification, assessment, prevention, and treatment of cancer using NFS1 biomarkers and modulators
Grant 10,947,596 - Bittinger , et al. March 16, 2
2021-03-16
Microfluidic Cell Culture Of Patient-derived Tumor Cell Spheroids
App 20200399573 - Barbie; David ;   et al.
2020-12-24
Inhibitors of EGFR and methods of use thereof
Grant 10,836,722 - Gray , et al. November 17, 2
2020-11-17
Combination Therapy Of Transcription Inhibitors And Kinase Inhibitors
App 20200338074 - Hammerman; Peter ;   et al.
2020-10-29
Methods Of Use And Pharmaceutical Combinations Of Hdac Inhibitors With Bet Inhibitors
App 20200323848 - WONG; Kwok-kin ;   et al.
2020-10-15
Combination therapy of transcription inhibitors and kinase inhibitors
Grant 10,702,527 - Hammerman , et al.
2020-07-07
Microfluidic Cell Culture Of Patient-derived Tumor Cell Spheroids
App 20200032187 - Barbie; David ;   et al.
2020-01-30
Inhibitors Of Egfr And Methods Of Use Thereof
App 20200002279 - GRAY; Nathanael S. ;   et al.
2020-01-02
Methods for treating cancer
Grant 10,501,537 - Wong Dec
2019-12-10
Microfluidic cell culture of patient-derived tumor cell spheroids
Grant 10,472,599 - Barbie , et al. Nov
2019-11-12
Compositions And Methods Of Modulating Anti-tumor Immunity
App 20190328874 - WONG; Kwok-Kin
2019-10-31
Inhibitors of EGFR and methods of use thereof
Grant 10,385,019 - Gray , et al. A
2019-08-20
Methods Of Diagnosing And Prognosing Lung Cancer
App 20190145977 - WONG; Kwok-Kin ;   et al.
2019-05-16
Combination Therapy Of Transcription Inhibitors And Kinase Inhibitors
App 20190015411 - Hammerman; Peter ;   et al.
2019-01-17
Ezh2 Inhibitors And Uses Thereof
App 20180297993 - Bradner; James E. ;   et al.
2018-10-18
Inhibitors Of Egfr And Methods Of Use Thereof
App 20180290975 - GRAY; Nathanael S. ;   et al.
2018-10-11
Combination Therapy Of Transcription Inhibitors And Kinase Inhibitors
App 20180169097 - Hammerman; Peter ;   et al.
2018-06-21
Microfluidic Cell Culture Of Patient-derived Tumor Cell Spheroids
App 20170369829 - Barbie; David ;   et al.
2017-12-28
Protection of renal tissues from ischemia through inhibition of the proliferative kinases CDK4 and CDK6
Grant 9,808,461 - DiRocco , et al. November 7, 2
2017-11-07
Methods For Discovering Therapeutics That Alter The Stability Of Target Proteins
App 20170306385 - Kaelin; William G. ;   et al.
2017-10-26
Plasmids Comprising Internal Ribosomal Entry Sites And Uses Thereof
App 20170292959 - Kaelin; William G. ;   et al.
2017-10-12
Methods For Treating Cancer
App 20170198039 - Wong; Kwok-Kin
2017-07-13
Tumor Suppressor And Oncogene Biomarkers Predictive Of Anti-immune Checkpoint Inhibitor Response
App 20170130271 - Wong; Kwok-Kin
2017-05-11
Activating JAK Kinase Biomarkers Predictive of Anti-Immune Checkpoint Inhibitor Response
App 20170115291 - Wong; Kwok-Kin ;   et al.
2017-04-27
Cyclin dependent kinase inhibitors and methods of use
Grant 9,616,062 - Sharpless , et al. April 11, 2
2017-04-11
Compositions And Methods For Identification, Assessment, Prevention, And Treatment Of Cancer Using Nfs1 Biomarkers And Modulators
App 20170051358 - Bittinger; Mark ;   et al.
2017-02-23
Combination Therapy For Cancer Using Bromodomain And Extra-terminal (bet) Protein Inhibitors
App 20160279141 - Bradner; James E. ;   et al.
2016-09-29
Use of anti-EGFR antibodies in treatment of EGFR mutant mediated disease
Grant 9,090,693 - Wong July 28, 2
2015-07-28
Lkb1/stk11 Deletion In Melanoma And Related Methods
App 20140378469 - Sharpless; Norman Edward ;   et al.
2014-12-25
Methods Of Treating Cancer
App 20140314791 - Wong; Kwok-Kin ;   et al.
2014-10-23
Protection Of Renal Tissues From Ischemia Through Inhibition Of The Proliferative Kinases Cdk4 And Cdk6
App 20130303543 - DiRocco; Derek Paul ;   et al.
2013-11-14
Susceptibility To Hsp90-inhibitors
App 20130023420 - Thomas; Roman ;   et al.
2013-01-24
Compositions, kits and methods for identification, assessment, prevention and therapy of cancer
Grant 8,168,602 - DePinho , et al. May 1, 2
2012-05-01
Susceptibility to HSP90-Inhibitors
App 20110319415 - Thomas; Roman ;   et al.
2011-12-29
Methods Of Diagnosing And Prognosing Lung Cancer
App 20110119776 - Wong; Kwok-Kin ;   et al.
2011-05-19
Use Of Anti-egfr Antibodies In Treatment Of Egfr Mutant Mediated Disease
App 20100166744 - Wong; Kwok-Kin
2010-07-01
Compositions, kits and methods for identification, assessment, prevention and therapy of cancer
App 20090297525 - Depinho; Ronald A. ;   et al.
2009-12-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed